Armstrong Teasdale LLP
Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids (“PNAs”) with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer
A functional biologically active particle conjugate useful for diagnosis and treating cancer as a bioportal comprises a nanoscale particle having associated therewith an intracellular targeting ligand comprising a PNA, or another nuclease resistant oligonucleotide analog such as MOE-mRNA (2′-methoxyethyl mRNA) or LNA (locked nucleic acid), having a sequence that binds selectively to an uniquely expressed or overexpressed mRNA specific to the cancer or disease state in a living mammal. In one aspect the uniquely overexpressed target specific to the cancer or disease state is the unr mRNA which can be targeted by the antisense sequence PNA50.
WASHINGTON UNIVERSITY IN ST. LOUIS
C A C C B C C A C C C C C C B
C12N A61K C12N C12N B82Y C12N C12N A61K C12N C12N C12N C01P C12N C12N B82Y
additional inventional additional additional additional additional inventional inventional additional additional inventional additional additional additional additional
Matthew L. Xiaoxu Jeffrey L. Xiankai Dipanjan Karen L. Raffaella Michael John John Stephen Huafeng
Becker Li Turner Sun Pan Wooley Rossin Welch Taylor Fang